Yesterday:
https://investor.sagerx.com/news-re...cs-board-directors-initiates-review-strategic
In addition, Sage announced that its Board has unanimously rejected the unsolicited, nonbinding proposal it received from Biogen Inc. (Nasdaq: BIIB) (“Biogen”on January 10, 2025, to acquire all outstanding shares of Sage not already owned by Biogen for $7.22 per share
- Forums
- ASX - By Stock
- NEU
- Neuren Media and Analyst Coverage
NEU
neuren pharmaceuticals limited
Add to My Watchlist
5.06%
!
$13.18

Neuren Media and Analyst Coverage, page-1508
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.18 |
Change
0.635(5.06%) |
Mkt cap ! $1.640B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $17.54M | 1.286M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 211 | $13.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.18 | 7 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 164 | 13.170 |
3 | 353 | 13.160 |
5 | 637 | 13.150 |
3 | 434 | 13.140 |
5 | 1518 | 13.130 |
Price($) | Vol. | No. |
---|---|---|
13.180 | 3 | 1 |
13.190 | 211 | 3 |
13.200 | 434 | 3 |
13.210 | 1745 | 5 |
13.220 | 1139 | 3 |
Last trade - 15.48pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online